Cancer & Metabolism

Papers
(The median citation count of Cancer & Metabolism is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
A role of arginase-1-expressing myeloid cells in cachexia117
FOXO3a/miR-4259-driven LDHA expression as a key mechanism of gemcitabine sensitivity in pancreatic ductal adenocarcinoma55
The classification of obesity based on metabolic status redefines the readmission of non-Hodgkin’s lymphoma—an observational study55
Aspirin reprogrammes colorectal cancer cell metabolism and sensitises to glutaminase inhibition42
Gut microbiota-derived indole-3-propionic acid promotes lymph node metastasis in gastric cancer via the aryl-hydrocarbon receptor signaling pathway40
GCN2-SLC7A11 axis coordinates autophagy, cell cycle and apoptosis and regulates cell growth in retinoblastoma upon arginine deprivation31
Measurement of mitochondria amount and clearance using flow cytometry: effect of mitophagy inhibitors in leukemia cells29
Lactate dehydrogenase A-coupled NAD+ regeneration is critical for acute myeloid leukemia cell survival28
Cone photoreceptor phosphodiesterase PDE6H inhibition regulates cancer cell growth and metabolism, replicating the dark retina response28
Ketomimetic nutrients remodel the glycocalyx and trigger a metabolic defense in breast cancer cells27
ACSL3 regulates lipid droplet biogenesis and ferroptosis sensitivity in clear cell renal cell carcinoma27
Identification and impact of microbiota-derived metabolites in ascites of ovarian and gastrointestinal cancer25
Correction: Cholesterol reprograms glucose and lipid metabolism to promote proliferation in colon cancer cells25
Transcriptome-driven constraint-based modelling reveals metabolic targets for ovarian cancer24
Glycemic status, insulin resistance, and mortality from lung cancer among individuals with and without diabetes24
Circulating metabolome landscape in Lynch syndrome23
In vivo characterization of the redox balance in IDH-wildtype glioblastomas: a J-difference edited MEGA-sLASER MRS study at 3T23
Magnetospirillum magneticum triggers apoptotic pathways in human breast cancer cells21
Autofluorescence imaging of endogenous metabolic cofactors in response to cytokine stimulation of classically activated macrophages21
Steatohepatitis-induced vascular niche alterations promote melanoma metastasis19
Dexmedetomidine promotes colorectal cancer progression mediated by gamma-aminobutyric acid signaling18
POU2F1 drives cholesterol biosynthesis and lipid remodeling through the DHCR24/ELOVL2 axis in endometrial cancer17
CYP19A1 regulates chemoresistance in colorectal cancer through modulation of estrogen biosynthesis and mitochondrial function16
CYP8B1 suppressed by Ras/ERK leads to cholesterol accumulation and bile acids reduction and facilitates hepatic tumorigenesis16
ATM inhibition blocks glucose metabolism and amplifies the sensitivity of resistant lung cancer cell lines to oncogene driver inhibitors14
Fasting-mimicking diet counteracts gut microbial dysbiosis in experimental lynch syndrome13
Pharmacological inhibition of Peroxisome Proliferation-Activated Receptor Delta (PPARδ) imparts selective leukemia cell death13
Disrupting Na+ ion homeostasis and Na+/K+ ATPase activity in breast cancer cells directly modulates glycolysis in vitro and in vivo13
VAV2 drives glycolytic reprogramming in esophageal squamous cell carcinoma via EIF3F-mediated MTA1 deubiquitination13
Sustained reductions in valine and isoleucine mediate anti-cancer pharmacological effects of inhibiting amino acid transporter LAT1 in cancer cells13
Characterizing OXPHOS inhibitor-mediated alleviation of hypoxia using high-throughput live cell-imaging13
PFKFB4 promotes M2 polarization of tumor-associated macrophages through aerobic glycolysis-mediated modification of histone H3K18 lactylation in hepatocellular carcinoma12
BMP4 upregulates glycogen synthesis through the SMAD/SLC2A1 (GLUT1) signaling axis in hepatocellular carcinoma (HCC) cells12
Long-acting Erwinia chrysanthemi, Pegcrisantaspase, induces alternate amino acid biosynthetic pathways in a preclinical model of pancreatic ductal adenocarcinoma12
Correction: STEAP4 inhibits cisplatin-induced chemotherapy resistance through suppressing PI3K/AKT in hepatocellular carcinoma12
Pancreatic cancer tumor organoids exhibit subtype-specific differences in metabolic profiles12
Comparative polar and lipid plasma metabolomics differentiate KSHV infection and disease states12
The integration of single-cell and metabolomics reveals the increase of oxidative phosphorylation during the liver metastasis of colorectal cancer11
STEAP4 inhibits cisplatin-induced chemotherapy resistance through suppressing PI3K/AKT in hepatocellular carcinoma11
Phosphoproteomics revealed cellular signals immediately responding to disruption of cancer amino acid homeostasis induced by inhibition of l-type amino acid transporter 111
Breast cancer cells that preferentially metastasize to lung or bone are more glycolytic, synthesize serine at greater rates, and consume less ATP and NADPH than parent MDA-MB-231 cells11
Lactate metabolism in clonal plasma cells and its therapeutic implications in multiple myeloma patients with elevated serum LDH levels11
Carboxylesterase 1-mediated endocannabinoid metabolism in skin: role in melanoma progression in BRafV600E/Pten−/− mice10
Altered acetyl-CoA metabolism presents a new potential immunotherapy target in the obese lung microenvironment10
Fatty acid synthase-derived lipid stores support breast cancer metastasis10
METTL16 regulates the mRNA stability of FBXO5 via m6A modification to facilitate the malignant behavior of breast cancer10
Impact of physiological media on acute myeloid leukemia bioenergetics and cell proliferation10
Statin use as a moderator on the association between metformin and breast cancer risk in women with type 2 diabetes mellitus10
The role of deoxycholic acid in macrophage polarization and remodeling of the tumor microenvironment during colorectal adenoma-carcinoma transition10
Tumor-intrinsic metabolic pathways essential for tumorigenesis and resistance to anti-PD1 in oncogenic Kras-driven lung adenocarcinoma10
Tumor cell death by ferroptosis contributes to an immunosuppressive tumor microenvironment in syngeneic murine models of cancer10
Unveiling the powerhouse: ASCL1-driven small cell lung cancer is characterized by higher numbers of mitochondria and enhanced oxidative phosphorylation10
Positron emission tomography imaging of the sodium iodide symporter senses real-time energy stress in vivo10
Integrative analysis of plasma metabolomics and proteomics reveals the metabolic landscape of breast cancer9
PER2 knockdown drives immunotherapy resistance in gastric cancer via metabolic reprogramming of myeloid-derived suppressor cells9
RHOF promotes Snail1 lactylation by enhancing PKM2-mediated glycolysis to induce pancreatic cancer cell endothelial–mesenchymal transition9
A HIF-1α inhibitor combined with palmitic acid and L-carnitine treatment can prevent the fat metabolic reprogramming under hypoxia and induce apoptosis in hepatocellular carcinoma cells8
Metabolic reprogramming in diffuse intrinsic pontine gliomas (DIPG): dual inhibition of mitochondrial oxidative phosphorylation and lactate metabolism to enhance anti-tumor and radiosensitizing effect8
Phosphatidylinositol promoted the proliferation and invasion of pituitary adenoma cells by regulating POU1F1 expression8
Glutaminolysis is associated with mitochondrial pathway activation and can be therapeutically targeted in glioblastoma8
Normalization of hepatic ChREBP activity does not protect against liver disease progression in a mouse model for Glycogen Storage Disease type Ia8
Exploratory profiling of metabolites in cerebrospinal fluid using a commercially available targeted LC-MS based metabolomics kit to discriminate leptomeningeal metastasis7
Normoxic HIFα-mediated metabolic rewiring in cancer as a novel therapeutic target of tumor heterogeneity7
Metabolic targeting of cyst(e)ine enhances carboplatin responsiveness in ovarian cancer7
PDK1- and PDK2-mediated metabolic reprogramming contributes to the TGFβ1-promoted stem-like properties in head and neck cancer7
Sulfatide imaging identifies tumor cells in colorectal cancer peritoneal metastases7
Correction: A role of arginase-1-expressing myeloid cells in cachexia7
SENP1 drives de novo cholesterogenesis via disrupting SUMOylation-mediated SREBP2-FBXW7 interaction7
CD36 inhibition enhances the anti-proliferative effects of PI3K inhibitors in PTEN-loss anti-HER2 resistant breast cancer cells7
Caloric restriction enhances radiosensitivity of colorectal tumors through the cGAS-STING pathway activation6
GDF15-mediated enhancement of the Warburg effect sustains multiple myeloma growth via TGFβ signaling pathway6
Computed tomography-measured body composition and survival in rectal cancer patients: a Swedish cohort study6
Metabolic alterations and cellular responses to β-Hydroxybutyrate treatment in breast cancer cells6
Scaffold-mediated switching of lymphoma metabolism in culture5
S-adenosylmethionine metabolism shapes CD8+ T cell functions in colorectal cancer5
Silencing of STEAP3 suppresses cervical cancer cell proliferation and migration via JAK/STAT3 signaling pathway5
Serine starvation suppresses the progression of esophageal cancer by regulating the synthesis of purine nucleotides and NADPH5
The FGL1-LAG-3 axis attenuates melanoma-induced cachexia in mice5
Cdk5 regulates glutamine metabolism in colorectal cancer via the EZH2-GLS1 axis5
Cholesterol reprograms glucose and lipid metabolism to promote proliferation in colon cancer cells5
The polyunsaturated fatty acid docosahexaenoic affects mitochondrial function in prostate cancer cells5
Assessment of lipolysis biomarkers in adipose tissue of patients with gastrointestinal cancer5
Unraveling the glycosphingolipid metabolism by leveraging transcriptome-weighted network analysis on neuroblastic tumors5
Improved VPS4B O-GlcNAc modification triggers lipid droplets transferring from adipocytes to nasopharyngeal carcinoma cells5
0.039570093154907